Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BIB vs. FBT: which is better?

Bottom line

BIB vs FBT: the short answer

BIB (ProShares Ultra Nasdaq Biotechnology) and FBT (First Trust NYSE Arca Biotechnology Index Fund) are both etfs.

But BIB is far broader, holding 267 positions to 32 for FBT, so beyond the top names it adds exposure FBT doesn't have.

FBT is cheaper at 0.55% vs 0.95% — a difference of $40 a year per $10,000 invested.

Over five years, FBT returned +4.3% a year vs −1.0% for BIB.

Updated Nov 19, 2026

BIB vs FBT side by side

BIBFBT
TypeETFETF
Fund familyProSharesFirst Trust
CategoryTechnology SectorTechnology Sector
Expense ratio0.95%0.55%
Annual cost per $10k$95$55
10-yr cost on $10k (prospectus)$1,401—
Max front loadNoneNone
12b-1 fee—0%
1-yr return+59.3%+24.1%
5-yr return (annualized)−1.0%+4.3%
10-yr return (annualized)+1.4%+6.3%
Best quarter+56.2%+27.8%
Worst quarter−42.7%−22.5%
Net assets (fund)$73.7M$2.8B
Number of holdings26732
Portfolio turnover29%37%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearBIBFBTDifference
2025+59.3%+24.1%+35.3%
2024−10.0%+5.8%−15.8%
2023−1.3%+2.3%−3.5%
2022−28.6%−4.6%−24.0%
2021−5.9%−3.6%−2.3%
2020+39.7%+12.9%+26.8%
2019+45.5%+19.8%+25.7%
2018−24.4%−0.2%−24.2%
2017+40.8%+37.0%+3.8%
2016−44.2%−19.6%−24.6%

Source: Fund prospectus bar charts

Holdings overlap

8 of BIB's top 25 holdings also appear in FBT's top 25.

Shared top holdings
HoldingBIBFBT
Vertex Pharmaceuticals, Inc.4.65%3.07%
Amgen, Inc.4.48%2.78%
Alnylam Pharmaceuticals, Inc.2.01%2.52%
Biogen, Inc.1.44%3.37%
Illumina, Inc.1.25%3.92%
United Therapeutics Corp.1.22%2.56%
Argenx SE1.19%3.13%
Incyte Corp.0.97%3.18%

Source: SEC Form N-PORT

BIB top 10

  1. N/a — 7.35%
  2. ProShares GENIUS Money Market ETF — 6.80%
  3. Gilead Sciences, Inc. — 4.66%
  4. Vertex Pharmaceuticals, Inc. — 4.65%
  5. Amgen, Inc. — 4.48%
  6. N/a — 3.94%
  7. N/a — 3.26%
  8. Regeneron Pharmaceuticals, Inc. — 3.21%
  9. N/a — 2.62%
  10. Alnylam Pharmaceuticals, Inc. — 2.01%

FBT top 10

  1. Corcept Therapeutics Inc — 5.60%
  2. Neogenomics Inc — 5.12%
  3. Veracyte Inc — 5.10%
  4. Bruker Corp — 4.32%
  5. Alkermes Plc — 4.24%
  6. Illumina Inc — 3.92%
  7. Krystal Biotech Inc — 3.87%
  8. Natera Inc — 3.79%
  9. Axsome Therapeutics Inc — 3.71%
  10. Neurocrine Biosciences Inc — 3.53%

FAQ

What is the difference between BIB and FBT?
BIB (ProShares Ultra Nasdaq Biotechnology) and FBT (First Trust NYSE Arca Biotechnology Index Fund) are both etfs. But BIB is far broader, holding 267 positions to 32 for FBT, so beyond the top names it adds exposure FBT doesn't have.
Which is cheaper, BIB or FBT?
FBT has the lower expense ratio (0.55%).
Should I own both BIB and FBT?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.